A detailed history of Exane Derivatives transactions in Merit Medical Systems Inc stock. As of the latest transaction made, Exane Derivatives holds 3 shares of MMSI stock, worth $312. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Previous 6 50.0%
Holding current value
$312
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$51.75 - $70.49 $155 - $211
-3 Reduced 50.0%
3 $0
Q1 2021

Apr 30, 2021

SELL
$52.56 - $60.99 $112,846 - $130,945
-2,147 Reduced 99.72%
6 $0
Q4 2020

Jan 27, 2021

BUY
$42.16 - $58.11 $6,113 - $8,425
145 Added 7.22%
2,153 $119,000
Q3 2020

Oct 06, 2020

SELL
$40.13 - $49.82 $7,544 - $9,366
-188 Reduced 8.56%
2,008 $87,000
Q2 2020

Jul 10, 2020

SELL
$28.84 - $45.65 $8,882 - $14,060
-308 Reduced 12.3%
2,196 $100,000
Q1 2020

Apr 17, 2020

BUY
$25.94 - $41.02 $64,953 - $102,714
2,504 New
2,504 $78,000

Others Institutions Holding MMSI

About MERIT MEDICAL SYSTEMS INC


  • Ticker MMSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 56,919,400
  • Market Cap $5.92B
  • Description
  • Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention produc...
More about MMSI
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.